Open Access
Export restrictions : a negative-sum policy response to the COVID-19 crisis
Loading...
Files
RSCAS_2020_23.pdf (794.53 KB)
Full-text in Open Access
License
Attribution 4.0 International
Cadmus Permanent Link
Full-text via DOI
ISBN
ISSN
1028-3625
Issue Date
Type of Publication
LC Subject Heading
Other Topic(s)
EUI Research Cluster(s)
Initial version
Published version
Succeeding version
Preceding version
Published version part
Earlier different version
Initial format
Citation
EUI RSCAS; 2020/23; Global Governance Programme-389; [Global Economics]
Cite
HOEKMAN, Bernard M., FIORINI, Matteo, YILDIRIM, Aydin, Export restrictions : a negative-sum policy response to the COVID-19 crisis, EUI RSCAS, 2020/23, Global Governance Programme-389, [Global Economics] - https://hdl.handle.net/1814/66828
Abstract
Many countries, including China, European member states, the European Union, India and the United States have put in place measures to restrict exports of medical products as part of their response to the COVID-19 pandemic. The objective is to allocate domestic supplies to national healthcare systems and citizens. These policies break supply chains that rely on sourcing of inputs from different countries, reduce access to critically needed supplies and foster excessive price spikes and volatility, and generate foreign policy tensions. Experience with widespread use of export restrictions by food exporting countries in times of market disruption and supply shortages suggests a priority for the G20 should be to work with industry to put in place systems to enhance access to information on production capacity, investments to boost supplies and address supply chain bottlenecks affecting production and trade in essential medical supplies.
Table of Contents
Additional Information
External Links
Publisher
Version
Research Projects
European Commission, 770680
Sponsorship and Funder Information
Supported by the EU Horizon 2020 research and innovation program under grant agreement No 770680 (RESPECT).